Intercept Pharmaceuticals Inc Umsatz Q / Q

Was ist das Umsatz Q / Q von Intercept Pharmaceuticals Inc?

Umsatz Q / Q von Intercept Pharmaceuticals Inc ist 14.44%

Was ist die Definition von Umsatz Q / Q?

Das vierteljährliche Umsatzwachstum im Vergleich zum Vorjahr ist die Steigerung des Umsatzes eines Unternehmens im Vergleich zur Leistung des entsprechenden Quartals eines Vorjahres, ausgedrückt in Prozent.

Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.

Umsatz Q / Q von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Intercept Pharmaceuticals Inc

Was macht Intercept Pharmaceuticals Inc?

we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.

Unternehmen mit umsatz q / q ähnlich Intercept Pharmaceuticals Inc